[CAS NO. 2102933-95-7] GSK-LSD1 2HCl
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [2102933-95-7]
Catalog
SLK-S7574
Brand
Selleck
CAS
2102933-95-7
DESCRIPTION [2102933-95-7]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 289.24 |
| Molecular Formula | C14H22Cl2N2 |
| SMILES | - |
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.4573 mL | 17.2867 mL | 34.5734 mL |
| 5 mM | 0.6915 mL | 3.4573 mL | 6.9147 mL |
| 10 mM | 0.3457 mL | 1.7287 mL | 3.4573 mL |
| 50 mM | 0.0691 mL | 0.3457 mL | 0.6915 mL |
Description
GSK-LSD1 2HCl is an irreversible, and selective inhibitor with of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B).
Targets
| LSD1 [1] (Cell-free assay) |
| 16 nM |
In vitro
GSK-LSD1 induces gene expression changes in cancer cell lines with average EC50 of < 5 nM and inhibits cancer cell line growth with average EC50 of < 5 nM.
References
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.